πŸ‡ΊπŸ‡Έ FDA
Patent

US 7279159

VEGF inhibitor polypeptides

granted A61KA61K38/00A61P

Quick answer

US patent 7279159 (VEGF inhibitor polypeptides) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P27/00, A61P27/02